Text across the video features a reflection from Swiss psychiatrist Carl Gustav Jung, which reads, “Even a happy life cannot be without a measure of darkness, and the word ‘happiness’ would lose its meaning if it were not balanced by sadness.”

View this post on Instagram

A post shared by Nicole Eggert (@_nicole_eggert)

Eggert expanded on that sentiment in her caption, writing, “Celebrating being alive and thriving while we yell and scream to go get screened!!!

“This month is heavy for me so lots of loud music and dancing #breastcancerawareness #feelyourselfup.”

October carries extra weight for Eggert, who has been candid about every stage of her cancer journey. She was diagnosed with stage 2 cribriform carcinoma breast cancer in early December 2023, after at first assuming her symptoms were related to menopause. A mammogram and three biopsies ultimately confirmed the cancer. She underwent chemotherapy, a mastectomy with lymph node removal, followed by a second mastectomy and breast reconstruction.

For Eggert, Breast Cancer Awareness Month is deeply personal, and she’s never shied away from letting fans see the hardest parts of her fight.

She initially chalked up her warning signs to menopause, but after a mammogram and three biopsies, she learned in 2023 that she had stage 2 invasive cribriform carcinoma, a rare, slow-growing type of breast cancer. What followed was an arduous road, which included: rounds of chemotherapy, a mastectomy and lymph node removal, and eventually a second mastectomy with breast reconstruction.

In December 2025, she shared the news every patient hopes for, describing her status as NED, or no evidence of disease.

Fans flooded the comments with love and encouragement. “Keep on dancing, Nicole!!!!” one follower wrote, while another offered, “I’ll dance with you!!!”

Others complimented her style and applauded the soundtrack, with one fan declaring, “2PAC always slaps!”

The post also struck a chord with those facing cancer themselves. One woman shared that she’s currently in treatment ahead of starting hormone blockers, having already undergone two surgeries. She described the past year as challenging but said she’s a fighter, showing just how much Eggert’s openness resonates with others still in the middle of their own battles.

SurvivorNetTV Presents: Maintaining a Positive Headspace

Eggert’s Ongoing Breast Cancer Treatment

Early-stage breast cancer, like the stage 2 diagnosis Eggert received, generally means the cancer is relatively small and hasn’t spread beyond the breast and nearby tissue, which often gives patients more treatment options and a better outlook.

Eggert’s own path to diagnosis started at home, when she found a lump during a breast self-exam. These checks are a simple but powerful way to catch changes early. Women should look and feel for lumps, swelling, shifts in breast shape, nipple changes, redness, rashes, or unusual discharge, and reach out to a doctor if anything seems off. Experts stress, however, that self-exams are not a replacement for routine mammograms, and the two work best together.

Speaking with People after her diagnosis, Eggert was frank about what she was facing. “I can definitely feel it. It’s there. It needs to be taken out,” she said. “So it’s just a matter of, do I have to do treatment before the surgery, or can they perform the surgery and then I do the treatment after?”

In addition to chemotherapy and her two mastectomies, Eggert also underwent radiation as part of her treatment. Afterward, she said she was weighing two options: a hysterectomy, or hormone therapy that would require a monthly estrogen-blocking injection for a decade along with two oral medications for five years. Fox News

In March 2026, the actress revealed on Instagram that she had undergone a hysterectomy after test results showed early signs of more cancer, sharing photos of her surgical scars. She noted that the procedure can help eliminate the risk of several cancers, including endometrial, cervical, ovarian and uterine cancers. A hysterectomy removes part or all of the uterus, often along with the cervix, according to the National Cancer Institute.

Women may need a hysterectomy for a number of reasons, and the decision is one a patient and her doctor weigh carefully together. Common reasons include endometrial or ovarian cancer, endometriosis, chronic pelvic pain, abnormal vaginal bleeding, and uterine fibroids.

In Eggert’s case, the surgery followed test results that showed early signs of more cancer. She didn’t share exactly what doctors found, though she did include the hashtag #uterinecancer in a social media post about the procedure.

The actress has also opened up about the medications she’s taking as she continues her fight against breast cancer, including Kisqali, letrozole, and Zoladex.

• Kisqali (ribociclib) is a targeted therapy known as a CDK4/6 inhibitor. It works by blocking certain proteins, called kinases, that help cancer cells divide and grow, which can slow the disease’s growth and spread.
• Letrozole is an aromatase inhibitor, meaning it blocks an enzyme the body uses to produce estrogen. Lowering estrogen levels helps slow the growth of tumors that rely on the hormone to grow, known as hormone receptor-positive breast cancers.
• Zoladex (goserelin) is a hormone therapy that signals the ovaries to stop producing estrogen, further cutting off the fuel that hormone-sensitive breast cancers need.

WATCH: How The Drug Kisqali and Endocrine Therapy Work For Hard-To-Treat Breast Cancers

Breast Cancer Guidelines Recommend Surveillance Based On Recurrence Risk

Guidance from the American Society of Clinical Oncology (ASCO), published online ahead of print in the Journal of Clinical Oncology on July 16, 2026, provides updated recommendations for monitoring breast cancer patients after they complete initial (adjuvant) treatment.

IT was developed by an ASCO Expert Panel led by Dr. Zeina Nahleh, Chair of the Department of Hematology-Oncology and Director of the Cleveland Clinic Florida Maroone Cancer Center, and Dr. Maryam Lustberg, Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center.

It emphasizes a personalized approach to follow-up care, recommending that screening and monitoring schedules be tailored to each patient’s individual risk of recurrence rather than following a one-size-fits-all protocol.

Key Takeaways From the Updated Guidelines:

• Routine monitoring remains important. Medical history reviews, physical exams, and mammograms continue to be key components of follow-up care after treatment.
• Some visits can happen virtually. Telehealth may be used for certain follow-up appointments, allowing patients to meet with their care team remotely when appropriate.
• Higher-risk patients may need closer monitoring. People with residual cancer after neoadjuvant chemotherapy, inflammatory breast cancer, certain inherited gene mutations (such as BRCA1/2), or those on specific combination therapies may benefit from more frequent follow-up visits, in some cases every 3 to 6 months for up to 10 years.
• Additional testing should be used selectively. The updated guidance provides recommendations on when blood-based tests and imaging beyond routine mammograms may be appropriate, rather than suggesting these tests for every breast cancer survivor.

Dr. Nahleh said in a statement, “The goal of [the] risk-stratified approach is to better address the heterogeneity of patients’ needs and account for these differences. It also emphasizes utilizing resources more effectively in light of the workforce shortage in oncology and rising health care costs.”

What This Means for Patients

Your breast cancer follow-up plan should reflect your individual risk and circumstances, rather than follow a standard checklist.

Patients at higher risk of recurrence may need more frequent or more detailed monitoring, while those at lower risk may not require as many follow-up visits.

Be sure to speak with your oncologist about your recurrence risk and ask how it affects the follow-up schedule they recommend.

It’s important to note that these guidelines may change as new evidence emerges, with tools such as circulating tumor DNA blood tests still being studied for their ability to predict recurrence but not yet recommended for routine monitoring.

Updated Guideline: Breast Cancer Follow-Up & Surveillance

New recommendations feature a risk-based approach to care, offering virtual or in-person visits, routine mammography, & tailored surveillance for high-risk patients.

Read the updated guideline: https://t.co/2Mhx2NK9qT pic.twitter.com/RbKa529iWR

— ASCO (@ASCO) August 26, 2026

When to Screen for Breast Cancer

Guidance on mammograms varies slightly by organization, which can cause confusion among patients, but we’re here to help.

In April 2024, the U.S. Preventive Services Task Force (USPSTF) updated its recommendation, advising all women at average risk to get a mammogram every other year starting at age 40 and continuing through age 74 — a change from its 2016 guidance, which set the starting age at 50.

The USPSTF said moving the starting age to 40 could save roughly 19% more lives, and noted that Black women face a 40% higher breast cancer mortality risk than white women, a disparity the earlier guidelines didn’t address.

The American Cancer Society’s guidance is close but not identical: annual mammograms starting at 45, moving to every other year (or annual, if preferred) starting at 55.

Screening For Breast Cancer

Women with a strong family history of breast cancer, a BRCA mutation, chest radiation before age 30, early menstruation (before 12), or dense breast tissue are considered higher risk and may need to start screening earlier—however, that conversation should happen with a doctor rather than by following a general guideline.

Questions To Ask Your Doctor

If you have a breast cancer screening coming up or have recently had one, you may have questions you want answered. SurvivorNet’s proprietary AI tool “My Health Questions” is designed specifically for patients and caregivers.

WATCH: How One Cancer Survivor and Her Sister Used “My Health Questions” to Navigate Care

This powerful resource is embedded across the SurvivorNet website and delivers structured responses grounded in clinical guidelines and medically reviewed research to help people better understand their treatment options and feel more confident navigating care.

My Health Questions can also help patients come up with useful questions ahead of their next appointment.

Contributing: SurvivorNet Staff

Learn more about SurvivorNet's rigorous medical review process.

---